CD8A and myeloid sarcoma: Here, 60% of tested MS patients harbored non-synonymous somatic mutations with enrichment in CD8+ cells in genes of an autoimmunity role such as ATM, CLIP2, IKFZF3, MAPK10, and STAT3 [77].